$\require{mediawiki-texvc}$

연합인증

연합인증 가입 기관의 연구자들은 소속기관의 인증정보(ID와 암호)를 이용해 다른 대학, 연구기관, 서비스 공급자의 다양한 온라인 자원과 연구 데이터를 이용할 수 있습니다.

이는 여행자가 자국에서 발행 받은 여권으로 세계 각국을 자유롭게 여행할 수 있는 것과 같습니다.

연합인증으로 이용이 가능한 서비스는 NTIS, DataON, Edison, Kafe, Webinar 등이 있습니다.

한번의 인증절차만으로 연합인증 가입 서비스에 추가 로그인 없이 이용이 가능합니다.

다만, 연합인증을 위해서는 최초 1회만 인증 절차가 필요합니다. (회원이 아닐 경우 회원 가입이 필요합니다.)

연합인증 절차는 다음과 같습니다.

최초이용시에는
ScienceON에 로그인 → 연합인증 서비스 접속 → 로그인 (본인 확인 또는 회원가입) → 서비스 이용

그 이후에는
ScienceON 로그인 → 연합인증 서비스 접속 → 서비스 이용

연합인증을 활용하시면 KISTI가 제공하는 다양한 서비스를 편리하게 이용하실 수 있습니다.

Controlled release pharmaceutical compositions from spherical granules in tabletted oral dosage unit form 원문보기

IPC분류정보
국가/구분 United States(US) Patent 등록
국제특허분류(IPC7판)
  • A61K-009/14
  • A61K-009/44
  • A61K-009/52
출원번호 US-0859617 (1992-03-23)
발명자 / 주소
  • Doyon Daniel J. (Florida NY) Ganesan Madurai G. (Suffern NY) Preston Wendy A. (Suffern NY) Sheth Nitin V. (Middletown NY)
출원인 / 주소
  • American Cyanamid Company (Stamford CT 02)
인용정보 피인용 횟수 : 142  인용 특허 : 0

초록

A controlled release pharmaceutical composition in oral dosage unit form comprising a tablet comprising a therapeutically effective number of active spherical granules comprising an effective amount of active medicament, a pharmaceutically acceptable normally solid diluent adapted to form a diffusab

대표청구항

A controlled release pharmaceutical composition in oral dosage unit form comprising a table comprising (A) a therapeutically effective number of active spherical granules comprising (i) about 10 to about 80 parts by weight of at least one active medicament; (ii) about 75 to about 10 parts by weight

이 특허를 인용한 특허 (142)

  1. Folger, Martin A.; Crowley, Samuel C.; Wilson, Amy J., Containers for compositions comprising meloxicam.
  2. Folger, Martin A.; Crowley, Samuel; Wilson, Amy, Containers for compositions comprising meloxicam.
  3. Oshlack, Benjamin; Huang, Hua-Pin; Masselink, John K.; Tonelli, Alfred, Controlled release hydrocodone.
  4. Oshlack, Benjamin; Huang, Hua-Pin; Masselink, John K.; Tonelli, Alfred, Controlled release hydrocodone.
  5. Oshlack, Benjamin; Huang, Hua-Pin; Masselink, John K.; Tonelli, Alfred, Controlled release hydrocodone.
  6. Oshlack, Benjamin; Huang, Hua Pin; Masselink, John K.; Tonelli, Alfred P., Controlled release hydrocodone formulations.
  7. Oshlack, Benjamin; Huang, Hua-Pin; Masselink, John K.; Tonelli, Alfred, Controlled release hydrocodone formulations.
  8. Oshlack, Benjamin; Huang, Hua-Pin; Masselink, John K.; Tonelli, Alfred, Controlled release hydrocodone formulations.
  9. Oshlack, Benjamin; Huang, Hua-Pin; Masselink, John K.; Tonelli, Alfred, Controlled release hydrocodone formulations.
  10. Oshlack, Benjamin; Huang, Hua-Pin; Masselink, John K.; Tonelli, Alfred, Controlled release hydrocodone formulations.
  11. Oshlack, Benjamin; Huang, Hua-Pin; Masselink, John K.; Tonelli, Alfred, Controlled release hydrocodone formulations.
  12. Oshlack, Benjamin; Huang, Hua-Pin; Masselink, John K.; Tonelli, Alfred, Controlled release hydrocodone formulations.
  13. Oshlack, Benjamin; Huang, Hua-Pin; Masselink, John K.; Tonelli, Alfred, Controlled release hydrocodone formulations.
  14. Oshlack, Benjamin; Huang, Hua-Pin; Masselink, John K.; Tonelli, Alfred, Controlled release hydrocodone formulations.
  15. Oshlack, Benjamin; Huang, Hua-Pin; Masselink, John K.; Tonelli, Alfred, Controlled release hydrocodone formulations.
  16. Oshlack, Benjamin; Huang, Hua-Pin; Masselink, John K.; Tonelli, Alfred, Controlled release hydrocodone formulations.
  17. Oshlack, Benjamin; Huang, Hua-Pin; Masselink, John K.; Tonelli, Alfred, Controlled release hydrocodone formulations.
  18. Oshlack, Benjamin; Huang, Hua-Pin; Masselink, John K.; Tonelli, Alfred, Controlled release hydrocodone formulations.
  19. Oshlack, Benjamin; Huang, Hua-Pin; Masselink, John K.; Tonelli, Alfred P., Controlled release hydrocodone formulations.
  20. Oshlack, Benjamin; Huang, Hua-Pin; Masselink, John K.; Tonelli, Alfred P., Controlled release hydrocodone formulations.
  21. Oshlack, Benjamin; Huang, Hua-Pin; Masselink, John K.; Tonelli, Alfred P., Controlled release hydrocodone formulations.
  22. Oshlack, Benjamin; Huang, Hua-Pin; Masselink, John K.; Tonelli, Alfred P., Controlled release hydrocodone formulations.
  23. Oshlack, Benjamin; Huang, Hua-Pin; Masselink, John K; Tonelli, Alfred, Controlled release hydrocodone formulations.
  24. Oshlack, Benjamin; Huang, Hua-Pin; Masselink, John; Tonelli, Alfred, Controlled release hydrocodone formulations.
  25. Oshlack, Benjamin; Huang, Hua-Pin; Masselink, John; Tonelli, Alfred, Controlled release hydrocodone formulations.
  26. Oshlack, Benjamin; Huang, Hua-Pin; Masselink, John; Tonelli, Alfred P., Controlled release hydrocodone formulations.
  27. Oshlack, Benjamin; Huang, Hua-Pin; Masselink, John; Tonelli, Alfred P., Controlled release hydrocodone formulations.
  28. Oshlack, Benjamin; Huang, Hua-Pin; Masselink, John; Tonelli, Alfred P., Controlled release hydrocodone formulations.
  29. Oshlack, Benjamin; Huang, Hua-Pin; Masselink, John; Tonelli, Alfred P., Controlled release hydrocodone formulations.
  30. Oshlack, Benjamin; Huang, Hua-Pin; Masselink, John; Tonelli, Alfred P., Controlled release hydrocodone formulations.
  31. Oshlack, Benjamin; Huang, Hua-Pin; Masselink, John; Tonelli, Alfred P., Controlled release hydrocodone formulations.
  32. Oshlack, Benjamin; Huang, Hua-Pin; Masselink, John; Tonelli, Alfred P., Controlled release hydrocodone formulations.
  33. Oshlack, Benjamin; Masselink, John K.; Huang, Hua-Pin; Tonelli, Alfred P., Controlled release hydrocodone formulations.
  34. Conte Ubaldo (Busto-Arsizio ITX) La Manna Aldo (Pavia ITX) Maggi Lauretta (Pavia ITX), Controlled release pharmaceutical tablet having lenticular form.
  35. Cervos Eric (Lyons FRX) Labourt-Ibarre Pierre (Lyons FRX) Statiotis Eraclis (Villette D\Anthon FRX), Coumarin spherules/beads having unique morphology.
  36. Habib Yacoub S. ; Shangraw Ralph ; Augsburger Larry L., Cushioning beads and tablet comprising the same capable of forming a suspension.
  37. Yoo, Jaedeok; Kumar, Sandeep; Monkhouse, Donald C., Dosage form exhibiting rapid disperse properties, methods of use and process for the manufacture of same.
  38. deVries, Tina; Gold, Lynn, Doxycycline metal complex in a solid dosage form.
  39. Cherukuri, S. Rao, Drug delivery systems.
  40. Rizk, Nabil, Extended release methazolamide formulation.
  41. Volpert, Sima; Avramoff, Avi, Extended release venlafaxine tablet formulation.
  42. Wortzman, Mitchell; Plott, R. Todd; Newhard, Steven B.; Watt, David, Extended-release minocycline dosage forms.
  43. Oshlack Benjamin ; Chasin Mark ; Huang Hua-Pin, Extruded multi-particulates.
  44. Oshlack Benjamin ; Chasin Mark ; Huang Hua-Pin, Extruded orally administrable opioid formulations.
  45. Bakan, Douglas A.; Jitpraphai, Waranush; Newhard, Steven B.; Wortzman, Mitchell S., Gastroretentive dosage forms for minocycline.
  46. Jean Paul Remon BE, High release solid preparation, preparation and use thereof.
  47. Henke, Stefan; Kruss, Bernd; Hassel, Bernhard; Kroff, Hans-Juergen; Folger, Martin A.; Daneck, Klaus; Prox, Axel, Highly concentrated stable meloxicam solutions.
  48. Henke, Stefan; Kruss, Bernd; Hassel, Bernhard; Kroff, Hans-Jurgen; Folger, Martin A.; Daneck, Klaus; Prox, Axel, Highly concentrated stable meloxicam solutions.
  49. Folger, Martin A.; Henke, Stefan; Hassel, Bernhard; Zierenberg, Bernd, Highly concentrated stable meloxicam solutions for needleless injection.
  50. Folger, Martin A.; Henke, Stefan; Hassel, Bernhard; Zierenberg, Bernd, Highly concentrated stable meloxicam solutions for needleless injection.
  51. Bunick, Frank J.; Lin, Feng, Ibuprofen composition.
  52. Bunick, Frank J.; Lin, Feng, Ibuprofen composition.
  53. Bunick,Frank J.; Lin,Feng, Ibuprofen composition.
  54. Connelly, Jr., Thomas V., Layered tablet water treatment compositions and method of use.
  55. Connelly, Jr.,Thomas V., Layered tablet water treatment compositions and method of use.
  56. Folger, Martin A.; Lehner, Stefan; Schmitt, Horst, Low concentration meloxicam tablets.
  57. Folger, Martin A.; Lehner, Stefan; Schmitt, Horst, Low concentration meloxicam tablets.
  58. Oshlack Benjamin ; Chasin Mark ; Huang Hua-Pin ; Sackler David, Melt-extruded orally administrable opioid formulations.
  59. Oshlack, Benjamin; Chasin, Mark; Huang, Hua-Pin; Sackler, David, Melt-extruded orally administrable opioid formulations.
  60. Benjamin Oshlack ; Hua-Pin Huang ; Mark Chasin, Melt-extrusion multiparticulates.
  61. Oshlack, Benjamin; Chasin, Mark; Huang, Hua-Pin, Melt-extrusion multiparticulates.
  62. Oshlack,Benjamin; Chasin,Mark; Huang,Hua Pin, Melt-extrusion multiparticulates.
  63. Burklow Eddie R. ; Kiel Jeffrey S. ; Ping Jeffrey H., Methazolamide composition and method of use.
  64. Rein, Hubert; Steffens, Klaus-Jurgen, Method for producing a water-insoluble amorphous or partially amorphous controlled release matrix.
  65. Wortzman, Mitchell; Plott, R. Todd; Newhard, Steven B.; Watt, David, Method for the treatment of acne and certain dosage forms thereof.
  66. Sackler Richard ; Kaiko Robert ; Goldenheim Paul, Method of treating humans with opioid formulations having extended controlled release.
  67. Sackler, Richard; Kaiko, Robert; Goldenheim, Paul, Method of treating humans with opioid formulations having extended controlled release.
  68. Oshlack, Benjamin; Huang, Hua-Pin; Masselink, John; Tonelli, Alfred, Methods of manufacturing oral dosage forms.
  69. Oshlack, Benjamin; Huang, Hua-Pin; Masselink, John K; Tonelli, Alfred, Methods of manufacturing oral formulations.
  70. Oshlack, Benjamin; Huang, Hua-Pin; Masselink, John K; Tonelli, Alfred, Methods of providing analgesia.
  71. Oshlack, Benjamin; Huang, Hua-Pin; Masselink, John; Tonelli, Alfred, Methods of providing analgesia.
  72. Wortzman, Mitchell; Plott, R. Todd; Bhatia, Kuljit; Patel, Bhiku, Minocycline oral dosage forms for the treatment of acne.
  73. Wortzman, Mitchell; Plott, R. Todd; Bhatia, Kuljit; Patel, Bhiku, Minocycline oral dosage forms for the treatment of acne.
  74. Wortzman, Mitchell; Plott, R. Todd; Bhatia, Kuljit; Patel, Bhiku, Minocycline oral dosage forms for the treatment of acne.
  75. Wortzman, Mitchell; Plott, R. Todd; Bhatia, Kuljit; Patel, Bhiku, Minocycline oral dosage forms for the treatment of acne.
  76. Wortzman, Mitchell; Plott, R. Todd; Bhatia, Kuljit; Patel, Bhiku, Minocycline oral dosage forms for the treatment of acne.
  77. Hayes, David; LoPore, Angelo; Lukas, Stefan; Quinn, Eugene, Modified release coated drug preparation.
  78. Oberegger, Werner; Eradiri, Okponanabofa; Zhou, Fang; Maes, Paul, Modified release tablet of bupropion hydrochloride.
  79. Ruddy Stephen B. ; Roberts Mary E., Nanoparticles containing the R(-)enantiomer of ibuprofen.
  80. Chang, Rong-Kun; Raoufinia, Arash; Shah, Niraj, Once daily formulations of tetracyclines.
  81. Chang, Rong-Kun; Raoufinia, Arash; Shah, Niraj, Once daily formulations of tetracyclines.
  82. Chang, Rong-Kun; Raoufinia, Arash; Shah, Niraj, Once daily formulations of tetracyclines.
  83. Chang, Rong-Kun; Raoufinia, Arash; Shah, Niraj, Once daily formulations of tetracyclines.
  84. Chang, Rong-Kun; Raoufinia, Arash; Shah, Niraj, Once daily formulations of tetracyclines.
  85. Chang, Rong-Kun; Raoufinia, Arash; Shah, Niraj, Once daily formulations of tetracyclines.
  86. Chen Chih-Ming ; Chou Joseph C. H., Once daily pharmaceutical tablet having a unitary core.
  87. Chih-Ming Chen ; Joseph C. H. Chou, Once daily pharmaceutical tablet having a unitary core.
  88. Oshlack, Benjamin; Wright, Curtis; Prater, Derek, Once-A day oxycodone formulations.
  89. Oshlack, Benjamin; Wright, Curtis; Prater, Derek, Once-a-day oxycodone formulations.
  90. Oshlack, Benjamin; Wright, Curtis; Prater, Derek, Once-a-day oxycodone formulations.
  91. Wimmer, Walter; Brogmann, Bianca; Hahn, Udo; Spitzley, Christof, Opioid analgesic.
  92. Chasin Mark ; Oshlack Benjamin ; Pedi ; Jr. Frank, Opioid formulations having extended controlled release.
  93. Chasin Mark ; Oshlack Benjamin ; Pedi ; Jr. Frank, Opioid formulations having extended controlled released.
  94. Li, Boying; Nangia, Avinash; Browder, Monte, Oral extended-release composition.
  95. Li,Boyong; Nangia,Avinash; Browder,Monte, Oral extended-release composition.
  96. Talwar, Naresh; Sen, Himadri; Staniforth, John N., Orally administered drug delivery system providing temporal and spatial control.
  97. Oshlack Benjamin ; Chasin Mark, Orally administrable opioid formulations having extended duration of effect.
  98. Oshlack Benjamin ; Chasin Mark, Orally administrable opioid formulations having extended duration of effect.
  99. Oshlack, Benjamin; Chasin, Mark, Orally administrable opioid formulations having extended duration of effect.
  100. Oshlack,Benjamin; Chasin,Mark, Orally administrable opioid formulations having extended duration of effect.
  101. Oshlack, Benjamin; Wright, Curtis; Prater, Derek, Oxycodone formulations.
  102. Leslie Stewart Thomas,GBX ; Knott Trevor John,GBX ; Mohammad Hasssan,GBX ; Prater Derek Allan,GBX, Pharmaceutical composition containing a fusible carrier and method for producing the same.
  103. Miller, Ronald Brown; Leslie, Stewart Thomas; Malkowska, Sandra Therese Antoinette; Prater, Derek Allan; Knott, Trevor John; Mohammad, Hassan, Pharmaceutical formulation.
  104. Ronald Brown Miller CH; Stewart Thomas Leslie GB; Sandra Therese Antoinette Malkowska GB; Derek Allan Prater GB; Trevor John Knott GB; Hassan Mohammad GB, Pharmaceutical formulation.
  105. Wright, Curtis; Oshlack, Benjamin; Breder, Christopher, Pharmaceutical formulation containing gelling agent.
  106. Wright, Curtis; Oshlack, Benjamin; Breder, Christopher, Pharmaceutical formulation containing gelling agent.
  107. Wright, Curtis; Oshlack, Benjamin; Breder, Christopher, Pharmaceutical formulation containing gelling agent.
  108. Wright, Curtis; Oshlack, Benjamin; Breder, Christopher, Pharmaceutical formulation containing gelling agent.
  109. Wright, Curtis; Oshlack, Benjamin; Breder, Christopher, Pharmaceutical formulation containing gelling agent.
  110. Wright, Curtis; Oshlack, Benjamin; Breder, Christopher, Pharmaceutical formulation containing gelling agent.
  111. Wright, Curtis; Oshlack, Benjamin; Breder, Christopher, Pharmaceutical formulation containing gelling agent.
  112. Wright, Curtis; Oshlack, Benjamin; Breder, Christopher, Pharmaceutical formulation containing gelling agent.
  113. Wright, Curtis; Oshlack, Benjamin; Breder, Christopher, Pharmaceutical formulation containing gelling agent.
  114. Wright, Curtis; Oshlack, Benjamin; Breder, Christopher, Pharmaceutical formulation containing gelling agent.
  115. Wright, Curtis; Oshlack, Benjamin; Breder, Christopher, Pharmaceutical formulation containing gelling agent.
  116. Wright, Curtis; Oshlack, Benjamin; Breder, Christopher, Pharmaceutical formulation containing gelling agent.
  117. Wright, Curtis; Oshlack, Benjamin; Breder, Christopher, Pharmaceutical formulation containing gelling agent.
  118. Wright, Curtis; Oshlack, Benjamin; Breder, Christopher, Pharmaceutical formulation containing gelling agent.
  119. Wright, Curtis; Oshlack, Benjamin; Breder, Christopher, Pharmaceutical formulation containing gelling agent.
  120. Wright, Curtis; Oshlack, Benjamin; Breder, Christopher, Pharmaceutical formulation containing gelling agent.
  121. Wright, Curtis; Oshlack, Benjamin; Breder, Christopher, Pharmaceutical formulation containing gelling agent.
  122. Wright, Curtis; Oshlack, Benjamin; Breder, Christopher, Pharmaceutical formulation containing gelling agent.
  123. Wright, Curtis; Oshlack, Benjamin; Breder, Christopher, Pharmaceutical formulation containing gelling agent.
  124. Langlois, Christian; Lanne, Jean-Yves, Pharmaceutical microspheres containing valproic acid for oral administration.
  125. Jacob, Jules; Coyle, Norman; West, Thomas G.; Monkhouse, Donald C.; Surprenant, Henry L.; Jain, Nemichand B., Rapid disperse dosage form containing levetiracetam.
  126. Jacob, Jules; Coyle, Norman; West, Thomas G; Monkhouse, Donald C.; Surprenant, Henry L.; Jain, Nemichand B., Rapid disperse dosage form containing levetiracetam.
  127. Jacob, Jules; Caputo, Kelly; Guillot, Micael; Sultzbaugh, Kenneth J.; West, Thomas G., Rapidly dispersible dosage form of oxcarbazepine.
  128. Jacob, Jules; Caputo, Kelly; Guillot, Micael; Sultzbaugh, Kenneth J.; West, Thomas G., Rapidly dispersible dosage form of oxcarbazepine.
  129. Jacob, Jules; Caputo, Kelly; Guillot, Micael; Sultzbaugh, Kenneth J.; West, Thomas G., Rapidly dispersible dosage form of oxcarbazepine.
  130. Jacob, Jules; Beach, Lauren; West, Thomas G.; Monkhouse, Donald C.; Surprenant, Henry L., Rapidly dispersible dosage form of topiramate.
  131. Saito Hiroshi (Tokyo JPX) Mikami Toshio (Tokyo JPX) Myo Nagayoshi (Tokyo JPX), Spherical granule, production method thereof and medicinal preparation using said granule.
  132. Debregeas Patrice,FRX ; Leduc Gerard,FRX ; Oury Pascal,FRX ; Suplie Pascal,FRX, Spheroids, preparation process and pharmaceutical compositions.
  133. Heafield Joanne,GBX ; Knott Trevor John,GBX ; Leslie Stewart Thomas,GBX ; Malkowska Sandra Therese Antoinette,GBX ; Miller Ronald Brown,CHX ; Prater Derek Allan,GBX ; Smith Kevin John,GBX, Sustained release compositions and a method of preparing pharmaceutical compositions.
  134. Heafield Joanne,GB2 ; Knott Trevor John,GB2 ; Leslie Stewart Thomas,GB2 ; Malkowska Sandra Therese Antoinette,GB2 ; Miller Ronald Brown,CHX ; Prater Derek Allan,GB2 ; Smith Kevin John,GB2, Sustained release compositions of morphine and a method of preparing pharmaceutical compositions.
  135. Friedman Michael,ILX ; Kohen Ron,ILX, Sustained-release pharmaceutical system for the delivery of antioxidants.
  136. Qasem, Jaber G.; Cathcart, Sumner H.; Irwin, Jack T., Tablets exhibiting reduced drug release variability.
  137. McKenna, William H.; Mannion, Richard O.; O'Donnell, Edward P.; Huang, Haiyong H., Tamper resistant dosage forms.
  138. McKenna, William H.; Mannion, Richard O.; O'Donnell, Edward P.; Huang, Haiyong H., Tamper resistant dosage forms.
  139. Johnston, Laura, Use of meloxicam for the long-term treatment of musculoskeletal disorders in cats.
  140. Henke, Stefan; Folger, Martin A.; Lehmann, Jens; Keilhofer, Diana C.; Kroff, Hans-Juergen; Herz, Nina, Water-soluble meloxicam granules.
  141. Henke, Stefan; Folger, Martin A.; Lehmann, Jens; Keilhofer, Diana C.; Kroff, Hans-Juergen; Herz, Nina, Water-soluble meloxicam granules.
  142. Henke, Stefan; Folger, Martin Andreas; Schmalz, Jens; Keilhofer, Diana Christine; Kroff, Hans-Juergen; Herz, Nina, Water-soluble meloxicam granules.
섹션별 컨텐츠 바로가기

AI-Helper ※ AI-Helper는 오픈소스 모델을 사용합니다.

AI-Helper 아이콘
AI-Helper
안녕하세요, AI-Helper입니다. 좌측 "선택된 텍스트"에서 텍스트를 선택하여 요약, 번역, 용어설명을 실행하세요.
※ AI-Helper는 부적절한 답변을 할 수 있습니다.

선택된 텍스트

맨위로